Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$591.7K
10 trades · 3 insiders
Net · 90d
$-591.7K
Insiders on file
28
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Berkley Neil Lindsay | Principal Financial Officer | 12 | $0 | $338.1K | 2026-10-14 |
| Wong-Sarad Grace | Principal Accounting Officer | 33 | $0 | $138.5K | 2026-10-14 |
| Rosenthal Arnon | Chief Executive Officer, Director | 81 | $0 | $22.68M | 2026-10-14 |
| GAROFALO ELIZABETH A. | Director | 11 | $0 | $0 | 2026-06-17 |
| Hammond Paula | Director | 13 | $0 | $86.2K | 2026-06-17 |
| Yaffe Kristine | Director | 16 | $0 | $26.7K | 2026-06-17 |
| Altmeyer Mark | Director | 6 | $0 | $0 | 2026-06-17 |
| SCHELLER RICHARD H | Director | 24 | $0 | $2.39M | 2026-06-17 |
| LAVIGNE LOUIS J JR | Director | 14 | $0 | $0 | 2026-06-17 |
| DESOUZA ERROL B | Director | 6 | $0 | $0 | 2026-06-17 |
| Kenkare-Mitra Sara | President and Head of R&D | 22 | $0 | $663.4K | 2025-12-03 |
| GRASSO MARC | Chief Financial Officer | 16 | $0 | $247.8K | 2025-06-02 |
| Romano Gary | Chief Medical Officer | 18 | $0 | $312.2K | 2025-03-03 |
| Wehner David M. | Director | 11 | $500.0K | $0 | 2024-06-12 |
| Polaris Venture Management Co. VI, L.L.C. | 10% Owner | 13 | $0 | $3.00M | 2024-05-29 |
| Polaris Venture Partners VI (AIV), L.P. | 10% Owner | 4 | $0 | $138.1K | 2024-04-30 |
| MCGUIRE TERRANCE | Director, 10% Owner | 36 | $0 | $3.14M | 2023-09-11 |
| Gerngross Tillman U. | Director | 11 | $0 | $0 | 2023-06-14 |
| King Robert | Chief Development Officer | 26 | $0 | $3.29M | 2022-10-01 |
| SULIMAN SHEHNAAZ | President and COO | 21 | $0 | $6.65M | 2021-12-13 |
| Paul Robert | Chief Medical Officer | 143 | $0 | $13.21M | 2021-08-09 |
| Yu Calvin | Vice President, Finance | 35 | $0 | $6.69M | 2021-07-06 |
| Oney Sabah | Chief Business Officer | 31 | $0 | $1.95M | 2020-10-01 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 63 | $7.82M | $97.19M | 2020-04-16 |
| ORBIMED CAPITAL LLC | 10% Owner | 3 | $0 | $7.41M | 2020-01-09 |
| OrbiMed Capital GP IV LLC | 10% Owner | 2 | $0 | $11.63M | 2019-08-07 |
| GORDON CARL L | Director, 10% Owner | 28 | $7.82M | $0 | 2019-05-10 |
| PVP VI (AIV) Feeder Corp. Holding Partnership, L.P. | 10% Owner | 12 | $0 | $0 | 2019-02-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-14 | 2026-10-15 | 978,750 | — | $0 | 978,750 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award | 2026-10-14 | 2026-10-15 | 217,500 | — | $0 | 2,512,100 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | A Award deriv | 2026-10-14 | 2026-10-15 | 190,000 | — | $0 | 190,000 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | A Award | 2026-10-14 | 2026-10-15 | 44,567 | — | $0 | 395,216 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-14 | 2026-10-15 | 83,435 | — | $0 | 83,435 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award | 2026-10-14 | 2026-10-15 | 55,555 | — | $0 | 161,570 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 132,500 | — | — | 132,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 132,500 | — | — | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 119,446 | — | — | 119,446 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 119,446 | — | — | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 417,213 | — | — | 417,213 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 417,213 | — | — | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 457,038 | — | — | 457,038 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 457,038 | — | — | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 520,000 | — | — | 520,000 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 520,000 | — | — | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 275,000 | — | — | 275,000 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 275,000 | — | — | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | A Award deriv | 2026-10-13 | 2026-10-15 | 500,000 | — | — | 500,000 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | D To issuer deriv | 2026-10-13 | 2026-10-15 | 500,000 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-13 | 2026-10-15 | 11,309 | — | — | 11,309 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | D To issuer deriv | 2026-10-13 | 2026-10-15 | 11,309 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-13 | 2026-10-15 | 11,552 | — | — | 11,552 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | D To issuer deriv | 2026-10-13 | 2026-10-15 | 11,552 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-13 | 2026-10-15 | 10,228 | — | — | 10,228 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | D To issuer deriv | 2026-10-13 | 2026-10-15 | 10,228 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-13 | 2026-10-15 | 20,454 | — | — | 20,454 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | D To issuer deriv | 2026-10-13 | 2026-10-15 | 20,454 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-13 | 2026-10-15 | 13,842 | — | — | 13,842 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | D To issuer deriv | 2026-10-13 | 2026-10-15 | 13,842 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2026-10-13 | 2026-10-15 | 20,000 | — | — | 20,000 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | D To issuer deriv | 2026-10-13 | 2026-10-15 | 20,000 | — | — | 0 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-09-04 | 2026-09-04 | 3,625 | $2.51 | $9.1K | 106,015 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-09-04 | 2026-09-04 | 3,625 | $2.51 | $9.1K | 106,015 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | S Sale | 2026-09-03 | 2026-09-04 | 29,251 | $2.66 | $77.8K | 350,649 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2026-09-03 | 2026-09-04 | 72,606 | $2.66 | $193.1K | 2,294,600 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-09-03 | 2026-09-04 | 5,165 | $2.67 | $13.8K | 109,640 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-09-03 | 2026-09-04 | 5,165 | $2.67 | $13.8K | 109,640 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | S Sale | 2026-09-03 | 2026-09-04 | 72,606 | $2.66 | $193.5K | 2,294,600 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | S Sale | 2026-09-03 | 2026-09-04 | 29,251 | $2.66 | $77.9K | 350,649 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-09-02 | 2026-09-04 | 656 | $2.75 | $1.8K | 114,805 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-09-02 | 2026-09-04 | 656 | $2.75 | $1.8K | 114,805 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | G Gift | 2026-08-19 | 2026-08-21 | 350,000 | — | $0 | 1,002,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | G Gift | 2026-08-19 | 2026-08-21 | 350,000 | — | $0 | 1,002,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | G Gift | 2026-08-19 | 2026-08-21 | 1,050,000 | — | $0 | 922,875 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | G Gift | 2026-08-19 | 2026-08-21 | 350,000 | — | $0 | 1,002,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | G Gift | 2026-08-19 | 2026-08-21 | 350,000 | — | $0 | 1,002,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | G Gift | 2026-08-19 | 2026-08-21 | 350,000 | — | $0 | 1,002,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | G Gift | 2026-08-19 | 2026-08-21 | 350,000 | — | $0 | 1,002,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer, Dir | G Gift | 2026-08-19 | 2026-08-21 | 1,050,000 | — | $0 | 922,875 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award | 2026-07-09 | 2026-07-09 | 20,000 | — | $0 | 115,461 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| Altmeyer Mark | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| Hammond Paula | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| Yaffe Kristine | Director | A Award deriv | 2026-06-17 | 2026-06-17 | 9,450 | — | $0 | 9,450 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 128,109 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 98,650 | SEC↗ |
| Altmeyer Mark | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 98,650 | SEC↗ |
| Hammond Paula | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 103,609 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 134,899 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 118,650 | SEC↗ |
| Yaffe Kristine | Director | A Award | 2026-06-17 | 2026-06-17 | 28,700 | — | $0 | 124,109 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-06-03 | 2026-06-03 | 3,475 | $1.88 | $6.5K | 95,461 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | S Sale | 2026-06-02 | 2026-06-03 | 19,360 | $1.97 | $38.1K | 379,900 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-06-02 | 2026-06-03 | 5,709 | $1.97 | $11.2K | 98,936 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2026-06-02 | 2026-06-03 | 87,216 | $1.97 | $171.8K | 2,367,206 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2026-06-01 | 2026-06-03 | 10,833 | — | $0 | 106,199 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-04-16 | 2026-04-17 | 1,820 | $2.65 | $4.8K | 104,645 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | A Award | 2026-03-15 | 2026-03-13 | 54,600 | — | $0 | 399,260 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2026-03-13 | 2026-03-13 | 116,246 | — | $0 | 2,454,422 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-03-10 | 2026-03-12 | 1,000 | $2.65 | $2.6K | 106,465 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-03-03 | 2026-03-03 | 3,367 | $2.08 | $7.0K | 107,465 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2026-03-02 | 2026-03-03 | 81,864 | $2.12 | $173.6K | 2,338,176 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-03-02 | 2026-03-03 | 8,071 | $2.12 | $17.1K | 110,832 | SEC↗ |
| Berkley Neil Lindsay | CFO & Chief Business Officer | S Sale | 2026-03-02 | 2026-03-03 | 29,649 | $2.12 | $62.9K | 344,660 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2026-02-26 | 2026-02-26 | 4,079 | $2.50 | $10.2K | 118,903 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2025-12-05 | 2025-12-08 | 4,753 | $1.21 | $5.8K | 122,982 | SEC↗ |
| Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | S Sale | 2025-12-03 | 2025-12-03 | 37,261 | $1.12 | $41.7K | 374,309 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2025-12-03 | 2025-12-03 | 41,687 | $1.12 | $46.7K | 501,652 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2025-12-03 | 2025-12-03 | 104,347 | $1.12 | $116.9K | 2,420,040 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2025-12-03 | 2025-12-03 | 8,056 | $1.12 | $9.0K | 127,735 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award deriv | 2025-11-10 | 2025-11-12 | 522,500 | — | $0 | 522,500 | SEC↗ |
| Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | A Award deriv | 2025-11-10 | 2025-11-12 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award deriv | 2025-11-10 | 2025-11-12 | 48,535 | — | $0 | 48,535 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2025-11-10 | 2025-11-12 | 174,167 | — | $0 | 2,524,387 | SEC↗ |
| Berkley Neil Lindsay | Chief Bus Ofcr & Interim CFO | A Award | 2025-11-10 | 2025-11-12 | 65,000 | — | $0 | 411,570 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | A Award | 2025-11-10 | 2025-11-12 | 32,343 | — | $0 | 135,791 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2025-09-02 | 2025-09-04 | 51,562 | $2.50 | $128.9K | 2,350,220 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2025-09-02 | 2025-09-04 | 23,638 | $2.50 | $59.1K | 543,339 | SEC↗ |
| Berkley Neil Lindsay | Principal Financial Officer | S Sale | 2025-09-02 | 2025-09-04 | 15,842 | $2.50 | $39.6K | 346,570 | SEC↗ |
| Wong-Sarad Grace | Principal Accounting Officer | S Sale | 2025-09-02 | 2025-09-04 | 5,910 | $2.50 | $14.8K | 103,448 | SEC↗ |
| Hammond Paula | Director | S Sale | 2025-08-26 | 2025-08-27 | 14,000 | $2.36 | $33.0K | 74,909 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award deriv | 2025-07-01 | 2025-07-01 | 45,700 | — | $0 | 45,700 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award deriv | 2025-07-01 | 2025-07-01 | 18,250 | — | $0 | 18,250 | SEC↗ |
| Berkley Neil Lindsay | Principal Financial Officer | A Award deriv | 2025-07-01 | 2025-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2025-07-01 | 2025-07-01 | 137,125 | — | $0 | 2,551,782 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award | 2025-07-01 | 2025-07-01 | 54,725 | — | $0 | 566,977 | SEC↗ |
| Yaffe Kristine | Director | S Sale | 2025-06-20 | 2025-06-23 | 1,000 | $1.44 | $1.4K | 95,409 | SEC↗ |
| Altmeyer Mark | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| Yaffe Kristine | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| Hammond Paula | Director | A Award deriv | 2025-06-11 | 2025-06-12 | 9,450 | — | $0 | 9,450 | SEC↗ |
| Altmeyer Mark | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 69,950 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 69,950 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 99,409 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 95,366 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 89,950 | SEC↗ |
| Yaffe Kristine | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 96,409 | SEC↗ |
| Hammond Paula | Director | A Award | 2025-06-11 | 2025-06-12 | 28,700 | — | $0 | 88,909 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2025-06-02 | 2025-06-04 | 52,087 | $1.34 | $69.8K | 2,414,657 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2025-06-02 | 2025-06-04 | 23,890 | $1.34 | $32.0K | 512,252 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2025-06-02 | 2025-06-04 | 16,488 | $1.34 | $22.1K | 296,072 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2025-05-02 | 2025-05-02 | 15,833 | — | $0 | 66,666 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2025-03-03 | 2025-03-05 | 16,306 | $1.47 | $24.0K | 332,977 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 40,330 | $1.47 | $59.3K | 2,466,744 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2025-03-03 | 2025-03-05 | 29,073 | $1.47 | $42.7K | 536,142 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2025-03-03 | 2025-03-05 | 18,091 | $1.47 | $26.6K | 312,560 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2024-12-02 | 2024-12-03 | 14,892 | $2.52 | $37.5K | 349,283 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2024-12-02 | 2024-12-03 | 26,500 | $2.52 | $66.8K | 565,215 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2024-12-02 | 2024-12-03 | 52,172 | $2.52 | $131.5K | 2,507,074 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2024-12-02 | 2024-12-03 | 16,489 | $2.52 | $41.6K | 330,651 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award | 2024-10-01 | 2024-10-02 | 184,380 | — | $0 | 364,175 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award | 2024-10-01 | 2024-10-02 | 300,000 | — | $0 | 591,715 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2024-10-01 | 2024-10-02 | 610,500 | — | $0 | 2,559,246 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | A Award | 2024-10-01 | 2024-10-02 | 216,400 | — | $0 | 347,140 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2024-09-03 | 2024-09-04 | 8,478 | $4.88 | $41.4K | 179,795 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2024-09-03 | 2024-09-04 | 13,926 | $4.88 | $68.0K | 291,715 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2024-09-03 | 2024-09-04 | 26,499 | $4.88 | $129.3K | 1,948,746 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2024-09-03 | 2024-09-04 | 7,297 | $4.88 | $35.6K | 130,740 | SEC↗ |
| SCHELLER RICHARD H | Director | S Sale | 2024-08-22 | 2024-08-23 | 44,250 | $5.16 | $228.3K | 35,000 | SEC↗ |
| Yaffe Kristine | Director | S Sale | 2024-08-12 | 2024-08-13 | 5,000 | $5.06 | $25.3K | 67,709 | SEC↗ |
| Hammond Paula | Director | S Sale | 2024-08-12 | 2024-08-13 | 10,500 | $5.06 | $53.1K | 60,209 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2024-08-02 | 2024-10-10 | 15,833 | — | $0 | 50,833 | SEC↗ |
| Hammond Paula | Director | A Award | 2024-06-12 | 2024-06-12 | 35,000 | — | $0 | 70,709 | SEC↗ |
| Wehner David M. | Director | A Award | 2024-06-12 | 2024-06-12 | 35,000 | — | $0 | 115,330 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2024-06-12 | 2024-06-12 | 35,000 | — | $0 | 79,250 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award | 2024-06-12 | 2024-06-12 | 35,000 | — | $0 | 61,250 | SEC↗ |
| Yaffe Kristine | Director | A Award | 2024-06-12 | 2024-06-12 | 35,000 | — | $0 | 72,709 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award | 2024-06-12 | 2024-06-12 | 35,000 | — | $0 | 70,709 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2024-06-03 | 2024-06-04 | 6,920 | $4.80 | $33.2K | 138,037 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2024-06-03 | 2024-06-04 | 13,206 | $4.80 | $63.4K | 305,641 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2024-06-03 | 2024-06-04 | 8,040 | $4.80 | $38.6K | 188,273 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2024-06-03 | 2024-06-04 | 25,135 | $4.80 | $120.6K | 1,975,245 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2024-05-29 | 2024-05-31 | 98,533 | — | $0 | 0 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2024-05-29 | 2024-05-31 | 98,533 | — | $0 | 98,533 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2024-05-29 | 2024-05-31 | 500,000 | — | $0 | 9,853,817 | SEC↗ |
| Polaris Venture Partners VI (A | 10% Owner | J Other | 2024-04-30 | 2024-05-02 | 98,533 | — | $0 | 98,533 | SEC↗ |
| Polaris Venture Partners VI (A | 10% Owner | J Other | 2024-04-30 | 2024-05-02 | 98,533 | — | $0 | 0 | SEC↗ |
| Polaris Venture Partners VI (A | 10% Owner | J Other | 2024-04-30 | 2024-05-02 | 500,000 | — | $0 | 10,353,817 | SEC↗ |
| DESOUZA ERROL B | Director | A Award deriv | 2024-03-19 | 2024-03-21 | 19,420 | — | $0 | 19,420 | SEC↗ |
| Altmeyer Mark | Director | A Award deriv | 2024-03-19 | 2024-03-21 | 19,420 | — | $0 | 19,420 | SEC↗ |
| DESOUZA ERROL B | Director | A Award | 2024-03-19 | 2024-03-21 | 41,250 | — | $0 | 41,250 | SEC↗ |
| Altmeyer Mark | Director | A Award | 2024-03-19 | 2024-03-21 | 41,250 | — | $0 | 41,250 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2024-03-04 | 2024-03-05 | 18,837 | $6.92 | $130.4K | 2,000,380 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2024-03-04 | 2024-03-05 | 5,716 | $6.92 | $39.6K | 144,957 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2024-03-04 | 2024-03-05 | 10,169 | $6.92 | $70.4K | 318,847 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2024-03-04 | 2024-03-05 | 6,001 | $6.92 | $41.5K | 196,313 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | G Gift | 2023-12-05 | 2023-12-06 | 9,459 | — | $0 | 26,250 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2023-12-04 | 2023-12-06 | 12,519 | $5.56 | $69.6K | 329,016 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2023-12-04 | 2023-12-06 | 4,574 | $5.56 | $25.4K | 150,673 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2023-12-04 | 2023-12-06 | 5,035 | $5.56 | $28.0K | 202,314 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2023-12-04 | 2023-12-06 | 23,831 | $5.56 | $132.5K | 2,019,217 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award deriv | 2023-10-01 | 2023-10-03 | 132,500 | — | $0 | 132,500 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award deriv | 2023-10-01 | 2023-10-03 | 54,500 | — | $0 | 54,500 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | A Award deriv | 2023-10-01 | 2023-10-03 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award deriv | 2023-10-01 | 2023-10-03 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2023-10-01 | 2023-10-03 | 397,600 | — | $0 | 2,043,048 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award | 2023-10-01 | 2023-10-03 | 163,600 | — | $0 | 341,535 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | A Award | 2023-10-01 | 2023-10-03 | 123,000 | — | $0 | 155,247 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award | 2023-10-01 | 2023-10-03 | 108,000 | — | $0 | 207,349 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | S Sale | 2023-09-11 | 2023-09-13 | 500,000 | $6.00 | $3.00M | 10,853,817 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | S Sale | 2023-09-11 | 2023-09-13 | 500,000 | $6.00 | $3.00M | 10,853,817 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2023-09-05 | 2023-09-06 | 1,114 | $5.19 | $5.8K | 32,247 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2023-09-05 | 2023-09-06 | 2,771 | $5.19 | $14.4K | 99,349 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2023-09-05 | 2023-09-06 | 6,214 | $5.19 | $32.3K | 177,935 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2023-09-05 | 2023-09-06 | 5,647 | $5.19 | $29.3K | 1,645,448 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 98,533 | — | $0 | 98,533 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 500,000 | — | $0 | 11,353,817 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 98,533 | — | $0 | 0 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 13,133 | — | $0 | 39,399 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 500,000 | — | $0 | 11,353,817 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 6,429 | — | $0 | 54,996 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 98,533 | — | $0 | 98,553 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2023-08-22 | 2023-08-24 | 98,533 | — | $0 | 0 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2023-07-15 | 2024-02-14 | 8,541 | — | $0 | 44,250 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| Hammond Paula | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| Yaffe Kristine | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| Wehner David M. | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| Gerngross Tillman U. | Director | A Award deriv | 2023-06-14 | 2023-06-15 | 12,360 | — | $0 | 12,360 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 35,709 | SEC↗ |
| Hammond Paula | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 35,709 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 35,709 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 35,709 | SEC↗ |
| Yaffe Kristine | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 35,709 | SEC↗ |
| Wehner David M. | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 80,330 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 48,567 | SEC↗ |
| Gerngross Tillman U. | Director | A Award | 2023-06-14 | 2023-06-15 | 26,250 | — | $0 | 2,644,319 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2023-06-02 | 2023-06-05 | 5,255 | $6.90 | $36.3K | 1,651,095 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2023-06-02 | 2023-06-05 | 2,617 | $6.90 | $18.1K | 102,120 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2023-06-02 | 2023-06-05 | 1,050 | $6.90 | $7.2K | 33,361 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2023-06-02 | 2023-06-05 | 4,092 | $6.90 | $28.2K | 184,149 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2023-03-17 | 2023-03-21 | 15,186 | $6.22 | $94.5K | 1,656,350 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2023-03-03 | 2023-03-21 | 42,990 | — | $0 | 1,671,536 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2023-03-02 | 2023-03-03 | 5,849 | $8.32 | $48.7K | 1,628,546 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | S Sale | 2023-03-02 | 2023-03-03 | 1,291 | $8.32 | $10.7K | 34,411 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | S Sale | 2023-03-02 | 2023-03-03 | 10,124 | $8.32 | $84.2K | 188,241 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2023-03-02 | 2023-03-03 | 3,238 | $8.32 | $26.9K | 104,737 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2022-12-02 | 2023-03-03 | 2,145 | $8.71 | $18.7K | 107,975 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 98,533 | — | $0 | 0 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 13,133 | — | $0 | 26,266 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 98,533 | — | $0 | 98,553 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 500,000 | — | $0 | 11,853,817 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 6,429 | — | $0 | 22,317 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 500,000 | — | $0 | 11,853,817 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 98,533 | — | $0 | 98,533 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2022-11-16 | 2022-11-18 | 98,533 | — | $0 | 0 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award deriv | 2022-10-01 | 2022-10-04 | 119,446 | — | $0 | 119,446 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award deriv | 2022-10-01 | 2022-10-04 | 53,576 | — | $0 | 53,576 | SEC↗ |
| King Robert | Chief Development Officer | A Award deriv | 2022-10-01 | 2022-10-04 | 14,384 | — | $0 | 14,384 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award deriv | 2022-10-01 | 2022-10-04 | 13,365 | — | $0 | 13,365 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | A Award deriv | 2022-10-01 | 2022-10-04 | 23,801 | — | $0 | 23,801 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | A Award | 2022-10-01 | 2022-10-04 | 179,169 | — | $0 | 1,634,395 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award | 2022-10-01 | 2022-10-04 | 80,365 | — | $0 | 198,365 | SEC↗ |
| King Robert | Chief Development Officer | A Award | 2022-10-01 | 2022-10-04 | 21,576 | — | $0 | 550,871 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award | 2022-10-01 | 2022-10-04 | 20,047 | — | $0 | 110,120 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | A Award | 2022-10-01 | 2022-10-04 | 35,702 | — | $0 | 35,702 | SEC↗ |
| King Robert | Chief Development Officer | S Sale | 2022-09-02 | 2022-09-07 | 176 | $10.62 | $1.9K | 529,295 | SEC↗ |
| Romano Gary | Chief Medical Officer | S Sale | 2022-09-02 | 2022-09-07 | 2,177 | $10.62 | $23.1K | 90,073 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| Gerngross Tillman U. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| Hammond Paula | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| MCGUIRE TERRANCE | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| Wehner David M. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| Yaffe Kristine | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 18,918 | — | $0 | 18,918 | SEC↗ |
| GAROFALO ELIZABETH A. | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 9,459 | SEC↗ |
| Gerngross Tillman U. | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 2,618,069 | SEC↗ |
| Hammond Paula | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 9,459 | SEC↗ |
| LAVIGNE LOUIS J JR | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 9,459 | SEC↗ |
| MCGUIRE TERRANCE | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 15,888 | SEC↗ |
| Wehner David M. | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 54,080 | SEC↗ |
| Yaffe Kristine | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 9,459 | SEC↗ |
| SCHELLER RICHARD H | Director | A Award | 2022-06-16 | 2022-06-21 | 9,459 | — | $0 | 9,459 | SEC↗ |
| King Robert | Chief Development Officer | S Sale | 2022-06-02 | 2022-06-06 | 177 | $8.71 | $1.5K | 529,471 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award deriv | 2022-05-27 | 2022-05-31 | 369,000 | — | $0 | 369,000 | SEC↗ |
| Romano Gary | Chief Medical Officer | A Award | 2022-05-27 | 2022-05-31 | 92,250 | — | $0 | 92,250 | SEC↗ |
| GRASSO MARC | Chief Financial Officer | A Award deriv | 2022-03-01 | 2022-03-03 | 450,000 | — | $0 | 450,000 | SEC↗ |
| King Robert | Chief Development Officer | S Sale | 2022-03-01 | 2022-03-03 | 287 | $15.57 | $4.5K | 528,404 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award deriv | 2022-01-03 | 2022-01-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award | 2022-01-03 | 2022-01-05 | 59,000 | — | $0 | 118,000 | SEC↗ |
| Kenkare-Mitra Sara | President and Head of R&D | A Award | 2022-01-03 | 2022-01-05 | 59,000 | — | $0 | 59,000 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 6,429 | — | $0 | 6,429 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 500,000 | — | $0 | 12,353,817 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 13,133 | — | $0 | 13,133 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 98,533 | — | $0 | 98,533 | SEC↗ |
| MCGUIRE TERRANCE | Director, 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 98,533 | — | $0 | 0 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 500,000 | — | $0 | 12,353,817 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 98,533 | — | $0 | 0 | SEC↗ |
| Polaris Venture Management Co. | 10% Owner | J Other | 2021-12-21 | 2021-12-23 | 98,533 | — | $0 | 98,533 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise deriv | 2021-12-13 | 2021-12-14 | 75,000 | — | $0 | 305,187 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-13 | 2021-12-14 | 10,898 | $21.73 | $236.8K | 102,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise | 2021-12-13 | 2021-12-14 | 75,000 | $17.23 | $1.29M | 177,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-13 | 2021-12-14 | 64,102 | $21.16 | $1.36M | 113,496 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise deriv | 2021-12-10 | 2021-12-14 | 75,000 | — | $0 | 380,187 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-10 | 2021-12-14 | 66,126 | $21.69 | $1.43M | 111,472 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise | 2021-12-10 | 2021-12-14 | 75,000 | $17.23 | $1.29M | 177,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-10 | 2021-12-14 | 8,874 | $22.33 | $198.2K | 102,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise deriv | 2021-12-09 | 2021-12-10 | 75,000 | — | $0 | 455,187 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-09 | 2021-12-10 | 2,643 | $23.40 | $61.8K | 102,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise | 2021-12-09 | 2021-12-10 | 75,000 | $17.23 | $1.29M | 177,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-09 | 2021-12-10 | 72,357 | $22.80 | $1.65M | 105,241 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise deriv | 2021-12-08 | 2021-12-10 | 55,187 | — | $0 | 134,026 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise deriv | 2021-12-08 | 2021-12-10 | 19,813 | — | $0 | 530,187 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-08 | 2021-12-10 | 36,511 | $22.56 | $823.7K | 141,087 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise | 2021-12-08 | 2021-12-10 | 55,187 | $10.24 | $565.1K | 177,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | S Sale | 2021-12-08 | 2021-12-10 | 38,489 | $23.01 | $885.6K | 102,598 | SEC↗ |
| SULIMAN SHEHNAAZ | President and COO | M Exercise | 2021-12-08 | 2021-12-10 | 19,813 | $17.23 | $341.4K | 122,411 | SEC↗ |
| King Robert | Chief Development Officer | S Sale | 2021-12-01 | 2021-12-03 | 250 | $20.09 | $5.0K | 528,691 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-11 | 2021-11-12 | 55,000 | $25.00 | $1.38M | 1,972,875 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-10 | 2021-11-12 | 55,000 | $25.00 | $1.38M | 2,027,875 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-09 | 2021-11-10 | 15,000 | $25.00 | $375.0K | 652,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-09 | 2021-11-10 | 15,000 | $25.00 | $375.0K | 652,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-09 | 2021-11-10 | 15,000 | $25.00 | $375.0K | 652,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-09 | 2021-11-10 | 55,000 | $25.00 | $1.38M | 2,082,875 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-08 | 2021-11-10 | 15,000 | $25.00 | $375.0K | 667,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-08 | 2021-11-10 | 15,000 | $25.00 | $375.0K | 667,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-08 | 2021-11-10 | 55,000 | $25.00 | $1.38M | 2,137,875 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-08 | 2021-11-10 | 15,000 | $25.00 | $375.0K | 667,500 | SEC↗ |
| Rosenthal Arnon | Chief Executive Officer | S Sale | 2021-11-05 | 2021-11-08 | 15,000 | $25.00 | $375.0K | 682,500 | SEC↗ |